Latest Financial Position News

Aurora Labs has advanced its micro gas turbine propulsion program with critical durability testing, a new Defence contract phase, and a strategic $5.5 million capital raise to scale manufacturing and commercialisation.

Encounter Resources has raised A$25 million through an institutional placement to fast-track its Aileron niobium-REE project and expand copper exploration across Western Australia and the Northern Territory.

Norwest Minerals advances its Bulgera Gold Project with successful deep drilling and promising heap leach economics, while preparing to test historic gold targets at Marymia East and expanding base metals exploration at Arunta West.

Way2VAT Ltd has completed its acquisition of RBC VAT Limited, boosting its European footprint and advisory services, while reporting a record quarterly revenue of A$1.89 million, up 34% year-on-year.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Australian Dairy Nutritionals reported a 66% year-on-year revenue increase in Q1 FY26, driven by strong nutritional powder sales and expanded distribution in China, while improving cash flow and production capacity.

Lynas Rare Earths delivered record quarterly sales revenue of A$200.2 million in Q1 FY26, bolstered by a successful $932 million equity raise and strategic partnerships aimed at securing critical rare earth supply chains outside China.

Dalaroo Metals has broadened its gold footprint in Côte d’Ivoire with four new project acquisitions while completing initial exploration in Greenland’s critical minerals sector. A $1 million capital raise supports these strategic moves as leadership changes unfold.

Vital Metals has raised A$6.8 million through a strategic placement and refreshed its board to accelerate development of its Nechalacho Rare Earths and Niobium Project in Canada, with further funding pending shareholder approval.

Gratifii Limited reported a remarkable 106% increase in cash receipts for 1Q FY26 despite seasonal and weather challenges, while nearing completion of its major platform integration.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir and is progressing regulatory discussions with the FDA to fast-track approval using the Animal Rule, backed by compelling preclinical data.

Caravel Minerals has appointed Primero Group as its preferred EPCM firm and secured a $15 million loan to fund its Definitive Feasibility Study, marking significant progress toward a Final Investment Decision for the Caravel Copper Project.